Wisia Wedzicha - UK
Wisia Wedzicha - UK
Wisia Wedzicha is Professor of Respiratory Medicine at the Royal Free and University College Medical School, University College London. She qualified from Oxford University and St Bartholomew’s Hospital Medical College. She has a major interest in the causes, mechanisms and impact of COPD exacerbations and has published extensively on this topic. She also is an expert on home ventilatory support in COPD patients and is currently the Chair of the British Thoracic Society working group on the home oxygen therapy and a member of the Department of Health’s External Stakeholders Advisory Group for the Home Oxygen Service. He was a member of the Guideline Development Group for the NICE COPD guidelines. She is a member on the External Reference Group of the COPD National Service Framework (NSF). She is currently Editor in Chief of the respiratory journal Thorax and on the Editorial Board of a number of respiratory journals..
| Competing Interests |
|---|
| 1) Have you in the past five years accepted the following from an organisation that may in any way gain or lose financially from the publication of papers in the BMJ? |
| a) Reimbursement for attending a symposium? |
| Yes |
| b) A fee for speaking? |
| Yes |
| c) A fee for organising education? |
| Yes |
| d) Funds for research? |
| Yes |
| e) Funds for a member of staff? |
| f) Fees for consulting? |
| Yes |
| 2) Have you in the past five years been employed by any organisation that may in any way gain or lose financially from the publication of papers in the BMJ? |
|
I am Editor in Cheif of Thorax and receive an honorarium for performing this role. |
| 3) Do you hold any stocks or shares in an organisation? |
| No |
| 4) Do you have any other competing financial interests? |
| No |
| 5) Do you have any other financial competing interests? If so, please specify. |
|
JAW has been paid honoraria for her role as Editor in Chief of Thorax and for Chairing the Respiratory Medicine Masterclass. In the past 5 years, JAW has received research grant funding from Glaxo Smith Kline, Astra Zeneca, Sanofi Aventis, Bayer and Boehringer Ingelheim. She has received honoraria for lectures and/or advisory boards from Glaxo Smith Kline, Astra Zeneca, Boehringer Ingelheim, Novartis, Bayer |
What's new
Online poll
Services
Print issues
